— Know what they know.
Not Investment Advice

CAPLIPOINT.BO BSE

Caplin Point Laboratories Ltd.
1W: -8.2% 1M: -3.1% 3M: +3.8% YTD: +52.0%
₹2,634.00 ($27.35)
-74.80 (-2.76%)
 
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 44 · ₹200.4B mcap · 20M float · 0.067% daily turnover
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₹200.4B ($2.1B)
52W Range1502.45-2990.6
Volume6,794
Avg Volume13,658
Beta0.19
Dividend₹8.00
Analyst Ratings
No analyst coverage
Company Info
CEOSridhar Ganesan
Employees4,199
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2002-02-26
Ashvich Tower
Chennai, TN 600096
IN
91 44 2496 8000
About Caplin Point Laboratories Ltd.

Caplin Point Laboratories Ltd., along with its subsidiaries, specializes in the development, manufacturing, marketing, and global export of both generic and branded pharmaceutical products, primarily operating within India. The company's comprehensive product line features a wide variety of dosage forms. These include oral preparations like tablets, capsules, and liquid orals; diverse injectable solutions such as prefilled syringes, lyophilized vials, and IV infusions; and topical applications such as ointments, creams, and gels. Its extensive offerings also encompass ophthalmic products, softgel capsules, powders for injection, suppositories, ovules, inhalers, sprays, and pre-mix bag formulations. Established in 1990, Caplin Point Laboratories Ltd. is headquartered in Chennai, India.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms